The interim injunction restrains Natco from manufacturing, distributing, exporting, offering to sell or selling any product which contains FMC’s leading insect control active ingredient

FMC Corporation announced that the Delhi High Court has granted the company an interim injunction against NATCO Pharma. The interim injunction restrains Natco from manufacturing, using, distributing, advertising, exporting, offering to sell and/or selling any product which contains chlorantraniliprole, FMC’s leading insect control active ingredient.

FMC filed the lawsuit against Natco at the Delhi High Court in October 2019 for potential patent infringement of certain Indian patents covering chlorantraniliprole. FMC sells chlorantraniliprole in India under the trade name Rynaxapyr active, which is the primary ingredient in Coragen and Ferterra insecticides.

Coragen and Ferterra insecticides are approved for controlling pests on rice, sugarcane, vegetables, maize as well as other important crops. These insecticides and their patented active ingredients are well known by farmers and recognized for their favourable safety and environmental profile, which has earned them a green label from India’s regulatory body.

“FMC Corporation invests heavily in research and development to bring innovations to farmers throughout India and around the world. We are deeply committed to ensuring farmers use genuine crop protection products from legitimate sources,” said Michael Reilly, Executive VP, General Counsel and Secretary, FMC.